Showing results (271-280 of 823) with videos related to
Sort By:
Pageof 83
Research and Practice in Thrombosis and Haemostasis|May 20, 2021
Anti-factor Xa activity assays of direct-acting oral anticoagulants during clinical care: An observational studySmrithi Sukumar, Melissa Cabero, Sharon Tiu, et al.Spine|December 19, 2006
The impact of disability compensation on long-term treatment outcomes of patients with sciatica due to a lumbar disc herniationSteven J Atlas, Yuchiao Chang, Robert B Keller, et al.American Heart Journal|May 26, 2009
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillationSonja V Sorensen, Sarah Dewilde, Daniel E Singer, et al.The American Journal of Medicine|May 30, 2002
Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetesRichard W Grant, Enrico Cagliero, Patricia Murphy-Sheehy, et al.Drug and Alcohol Dependence|July 26, 2017
Examining the effects of illicit drug use on tobacco cessation outcomes in the Helping HAND 2 randomized controlled trialJoanna M Streck, Susan Regan, Yuchiao Chang, et al.Journal of the American Heart Association|July 9, 2013
Limited English proficient patients and time spent in therapeutic range in a warfarin anticoagulation clinicFátima Rodriguez, Clemens Hong, Yuchiao Chang, et al.Circulation. Cardiovascular Quality and Outcomes|August 27, 2025
Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase StudyDae Hyun Kim, Darae Ko, Daniel E Singer, et al.Journal of General Internal Medicine|February 1, 2011
Food insufficiency and health services utilization in a national sample of homeless adultsTravis P Baggett, Daniel E Singer, Sowmya R Rao, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Community-acquired pneumonia due to Escherichia coliThomas J. Marrie, Michael J. Fine, D. Scott Obrosky, et al.Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA TrialShao-Wei Lo, Darae Ko, Dae Hyun Kim, et al.Pageof 83